SF - If one of the BP's happen to make a deal to take out R or Z in their entirety there is a reasonable chance that that company could lead in the epigenetics space for quite a few years. Some of the recent information we are reading about today we have heard about from the company 5 to 10 years ago. In the drug development business that's a lifetime ago.
I will steal one of Bears lines here..."go RVX go"
tada